![Magnus Matstoms](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Magnus Matstoms
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Carnegie Fond AB
![]() Carnegie Fond AB Investment ManagersFinance Carnegie Fond AB (CF) is a wholly-owned subsidiary of Carnegie Investment Bank AB, in turn a wholly-owned subsidiary of the Stockholm-based financial group D.Carnegie & Co AB (ST: CAR). CF is located in Stockholm. The firm is a fund management specialist. They manage mutual funds for the parent group and sub-advise portfolios for third-parties. CF cooperates closely with their fellow subsidiary Carnegie Asset Management AB.
9
| Extinct | Investment Managers | 9 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Magnus Matstoms
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Carnegie Investment Bank AB
![]() Carnegie Investment Bank AB Investment Banks/BrokersFinance Carnegie Investment Bank AB is the broker/delear subsidiary of Carnegie Holding AB in Sweden. Headquartered in Stockholm, the firm was founded in 1803 and offers institutional clients several services within research, equity sales and equity capital market transactions (ECM). The Fixed Income unit offers bond research and sales. Carnegie Investment Bank’s research and equity sales enjoy a global position in Nordic equities. | Investment Banks/Brokers | Corporate Officer/Principal Analyst-Equity Analyst-Equity | |
Rhenman & Partners Asset Management AB
![]() Rhenman & Partners Asset Management AB Investment ManagersFinance Rhenman & Partners Asset Management AB (Rhenman & Partners) is an independent Swedish alternative investment management firm which was founded in 2008 by a group of senior asset management industry executives including Henrik Rhenman and Göran Nordström. Headquartered in Stockholm, the firm is exclusively focused on the healthcare sector and manages the Rhenman Healthcare Equity L/S Fund, supported by a Scientific Advisory Board with a network of scientists and experts at renowned scientific institutions, including the Karolinska Institute and the University of Uppsala. | Investment Managers | Founder | |
KCIF Fund Management AB | Director/Board Member | ||
Stockholm School of Economics | College/University | Graduate Degree | |
GRANGEX AB | Other Metals/Minerals | Director/Board Member | |
Lannebo Fonder AB
![]() Lannebo Fonder AB Investment ManagersFinance Lannebo Fonder AB (Lannebo) is an independent fund management firm headquartered in Stockholm, Sweden. The firm was founded in 2000 by Anders Lannebo together with a group of portfolio managers from fund management companies of Nordic banks. Lannebo manages a range of Swedish mutual funds for individuals and institutional clients. Lannebo Fonder is a socially responsible investor and a signatory to the United Nations-supported Principles for Responsible Investment (UNPRI). | Investment Managers | Portfolio Manager-Equities | |
Healthinvest Partners AB
![]() Healthinvest Partners AB Investment ManagersFinance Healthinvest Partners AB (Healthinvest) is an alternative investment management firm headquartered in Stockholm, Sweden. The firm was founded by Anders Hallberg and Carl Bennet in 2006. They are owned by Atle Investment Management AB, which is a subsidiary of Bure Equity AB (STO: BURE). Healthinvest manages HealthInvest Alpha Fund – which is an actively managed global healthcare fund with a value-based approach, and HealthInvest Sustainable Healthcare – a global healthcare fund where the investment philosophy is characterized by medical progress and innovation with a strong focus on sustainability. In addition, the firm manages the fund Avanza Healthcare on behalf of Avanza. | Investment Managers | Founder | |
Astra Arcus AB | Corporate Officer/Principal | ||
Karolinska Institutet | College/University | Doctorate Degree | |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | Investment Trusts/Mutual Funds | Chief Investment Officer | |
SV Health Managers LLP
![]() SV Health Managers LLP Investment ManagersFinance SV Health Managers LLP (SVHM) is the investment management subsidiary of SV Life Sciences Advisers LLP in the UK. Established in 2005, the firm was formerly known as SV Life Sciences Managers LLP and changed their name to SV Health Managers LLP in 2017. Based in London, the firm manages the International Biotechnology Trust plc (LSE: IBT), an investment trust vehicle listed on the London Stock Exchange into which corporate and private investors may invest. | Investment Managers | Portfolio Manager-Equities | |
KDev Oncology AB
![]() KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Chief Executive Officer | |
Carl Harald Janson Förvaltning AB | Corporate Officer/Principal | ||
Aprea Personal AB | Director/Board Member | ||
Nordea Investment Management AB
![]() Nordea Investment Management AB Investment ManagersFinance Nordea Investment Management AB (NIM) is the Swedish investment management subsidiary of Nordea Asset Management Holding AB, itself a subsidiary of Nordea Bank ABp (HEL: NDA-FI, ADR: NRBAY) in Finland. Founded in 1954 as Merita Nordbanken Investment Management, the firm became Nordea Investment Management AB in 2001 when the Nordea name, an abbreviation of Nordic ideas, replaced Unibank, Nordbanken, Merita and Christiania Bank in a joint renaming operation. Headquartered in Stockholm, NIM manages a range of Swedish funds including pension funds, hedge funds, Luxembourg-domiciled SICAVs and funds registered in other Nordic countries for institutional clients. | Investment Managers | President | |
Aprea Therapeutics AB
![]() Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Corporate Officer/Principal | |
Akinion Pharmaceuticals AB
![]() Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
ClanoTech AB
![]() ClanoTech AB Pharmaceuticals: MajorHealth Technology ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells. Its Alpha5beta1-integrin is strongly up-regulated in fibroblast when switching to the fibrotic state and in scars after glaucoma surgery. Its strategy spans from therapeutic areas with high commercial potential as wet Age Regulated Macular Degeneration to ophthalmology niche indications with orphan drug opportunity such as developing advent in glaucoma surgery techniques. The company was founded by Yihai Cao in 2006 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
ONCOPEPTIDES AB | Pharmaceuticals: Major | Director/Board Member | |
Karolinska Development AB (Private Equity)
![]() Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | Investment Managers | Private Equity Investor | |
C Worldwide Asset Management Fondsmæglerselskab A/S (Sweden)
![]() C Worldwide Asset Management Fondsmæglerselskab A/S (Sweden) Investment ManagersFinance C Worldwide Asset Management Fondsmæglerselskab A/S (Sweden) (C Worldwide AM) is the investment advisory division of Carnegie Asset Management Fondsmæglerselskab A/S, the wholly-owned subsidiary of Cam Group Holding A/S in Sweden. Formerly known as Carnegie Asset Management Fondsmæglerselskab A/S (Sweden), the firm is based in Stockholm and specializes in discretionary asset management products and structured portfolios, catering to high-net worth individuals and institutional investors primarily in the Nordic countries. They utilize external distribution channels and Carnegie Private Banking to provide products to the retail market. C Worldwide AM cooperates closely with Carnegie Fond AB which manages mutual funds for the parent group. The Carnegie group also has offices in Norway, Denmark, Finland, Luxembourg, Switzerland, Great Britain and the US. | Investment Managers | Chief Investment Officer | |
Vasakronan AB
![]() Vasakronan AB Real Estate DevelopmentFinance Vasakronan AB operates as a real estate development company. The company owns, develops, and manages commercial properties. Its properties are situated in clusters and offer supplementary services to the tenants. The firm's business activities also include office and retail leasing, and green leases and green offices development. The company was founded in 1955 and is headquartered in Stockholm, Sweden. | Real Estate Development | Director/Board Member | |
Fjärde AP-fonden
![]() Fjärde AP-fonden Investment ManagersFinance Fjärde AP-fonden (AP4) is the pension fund management subsidiary of the Government of Sweden. Also known as Fourth AP Fund, the firm was founded in 1974 and is headquartered in Stockholm. AP4 provides pension fund management services for employees of Swedish corporations. The firm manages The Fourth Swedish National Pension Fund, which is a buffer fund for the earnings-related part of the state pension scheme. They are a socially responsible investor and signatory to the UN Principles for Responsible Investment which integrates ESG criteria in their investment processes. | Investment Managers | Chief Executive Officer | |
Trill Invest AB
![]() Trill Invest AB Financial ConglomeratesFinance Trill Invest AB is an investment services provider founded in 2020. The private company is based in Stockholm, Sweden. The Swedish company's main focus is on investment services. | Financial Conglomerates | Corporate Officer/Principal |
Statistik
International
Schweden | 30 |
Vereinigtes Königreich | 3 |
Sektoral
Finance | 17 |
Health Technology | 7 |
Consumer Services | 3 |
Non-Energy Minerals | 2 |
Miscellaneous | 2 |
Operativ
Portfolio Manager-Equities | 13 |
Chief Investment Officer | 11 |
Director/Board Member | 10 |
Corporate Officer/Principal | 6 |
Chief Executive Officer | 5 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Magnus Matstoms
- Unternehmensverbindungen